核转录因子-κB通路与肿瘤的研究进展

摘要/Abstract

中图分类号:

R73-37

王东华, 贾喜花, 郑淑君, 赵霞, 张丙信, 王晓博. 核转录因子-κB通路与肿瘤的研究进展[J]. 承德医学院学报, 2017, 34(6): 508-510.

[1] Sun SC.The noncanonical NF-κB pathway[J].Immunol Rev,2012,246(1):125-140.
[2] Sun SC.Non-canonical NF-κB signaling pathway[J].Cell Res,2011,21(1):71-85.
[3] Karin M,Cao Y,Greten FR,et al.NF-kappaB in cancer:from innocent bystander to majorCulprit[J].Nat Rev Cancer,2002,2(4):301-310.
[4] Lee SA,Kim HJ,Chang KC,et al.DHA and EPA down-regulate COX-2 expression through suppression of NF-κB activity in LPS-treated human umbilical vein endothelial cells[J]. Korean J Physi and Pharmac,2009,13(4):301-307.
[5] Trebec-Reynolds DP,Voronov I,Heersche JN,et al.VEGF-A expression in osteoclasts is regulated by NF-kappaB induction of HIF-l alpha[J].J Cell Biochem,2010,110(2):343-351.
[6] Chu SH,Lim JW,Kim DG,et al.Down-regulation of Bcl-2 ismediated by NF-kappaB activation in Helicobacter pylori-induced apoptosis of gastric epithelial cells[J].Scand J Gastroenterol, 2011,46(2):148-155.
[7] 李春雷,陈钟.NF-κB和PTEN蛋白在肝细胞肝癌中的表达及其意义[J].南通大学学报(医学版),2013,33(4):291-295.
[8] Yu HB,Zhang HF,Zhang X,et al.Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism[J].Hepatogastroenterology, 2010,57(102/103):1241-1246.
[9] 张宇红,窦科峰.核因子-κB、bcl-2在肝癌的表达及其相关性[J].第四军医大学学报,2004,25(10): 918-920.
[10] Hsieh MJ,Lin CW,Yang SF,et al.Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells[J].British J Pha,2014,171(12):3037-3050.
[11] Zaynagetdinov R,Stathopoulos GT,Sherrill TP,et al.Epithelial nuclear factor-kB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes[J].Oncogene,2012, 31(26):3164-3176.
[12] Davies AM,Lara PN Jr,Mack PC,et al.Incorporating bortezomibinto the treatment of lung cancer[J].Clin Cancer Res,2007,13(15):4647s-4651s.
[13] Yang L,Zhou Y,Li Y,et al.Mutations of p53 and KRAS activate NF-kappaB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells[J].Cancer Lett,2015,357(2):520-526.
[14] Zhang L,Ruan J,Yan L,et al.Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells[J]. Molecules,2012,17(4):3736-3750.
[15] Lee H,Kim JS,Kim E.Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways[J].PLoS One,2012,7(11): e50624.
[16] Zeng Q, Li S, Zhou Y, et al.Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression[J]. Cytokine,2014,65(1):24-32.
[17] Cheng X,Gu J,Zhang M,et al.Astragaloside IV inhibits migration and invasionin human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway[J].Int Immunopharmacol, 2014,23(1):304-313.
[18] Gao P,Gao YJ,Liang HL.Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer[J].Asian Pac J Trop Med,2015,8(3):220-224.
[19] Kumar M,Allison DF,Baranova NN,et al.NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells[J].PLoS One,2013,8(7):1-10.
[20] Li J,Jia H,Xie L,et a1.Association of constitutive nuclear factor-κB activation with aggressive aspects and poor prognosis in cervical cancer[J].Int J Gynecol Cancer,2009, 19(8):1421-1426.
[21] James MA,Lee JH,Klingelhutz AJ.Human papillomavirus type 16 E6 activates NF-κB,induces cIAP-2 expression,and protects against apoptosis in a PDZ binding motif-dependent manner[J]. J Virol,2006,80(11):5301-5307.
[22] Chen HW,Liu SS,Miao LF,et al.Inhibitory effect of lanthanum chloride on migration and invasion of cervical cancer cells[J].J Rare Earths,2013,31(1):94-100.
[23] Sahin K,Tuzcu M,Basak N,et al.Sensitization of cervical cancer cells to cisplatin by genistein:the role of NF-κB and Akt/mTOR signaling pathways[J].J Oncol,2012,2012(3): 461562.
[24] 邢丽娜,刘晓.NF-κB抑制对宫颈癌HeLa细胞放疗敏感性影响的观察[J].中华肿瘤防治杂志,2008,15(21):1636-1638.
[25] Sasaki N,Morisaki T,HashiZume K,et aI.NucIear factor-kappaB p65(ReIA) transcription factor is constitutiveIy activated in human gastric carcinoma tissue[J].CIin Cancer Res, 2001,7(12):4136-4142.
[26] 修丽娟,孙大志,刘宁宁,等.幽门螺杆菌阳性胃癌组织中RUNX3、NF-κB p65蛋白表达及临床意义[J].中华临床医师杂志(电子版),2016,10(1):11-15.
[27] 李勇,耿建磊,檀碧波,等.胃癌组织核转录因子κB p65蛋白表达与肿瘤多药耐药性的关系[J].中国全科医学,2016,19(2):238-241.
[28] Bailey ST,Miron PL,Choi YJ,et al.NF-kappaB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth[J].Mol Cancer Res,2014, 12(3):408-420.
[29] Duru N,Candas D,Jiang G,et al.Breast cancer adaptive resistance: HER2 and cancer stem repopulation in a heterogeneous tumor society[J].Cancer Res Clin Oncol,2014,140(1):l-14.
[30] Shibata A,Nagaya T,Imai T,et al.Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells[J].Breast Cancer Res and Treat,2002,73(3): 237-243.
[31] Chen YJ,Yeh MH,Yu MC,et al.Lapatinib-induced NF-kappaB activation sensitizes triple- negative breast cancer cells to proteasome inhibitors[J].Breast Cancer Res,2013, 15(6):R108.
[32] 濮勇,陈锁成.核转录因子-κB在结肠癌中的表达及临床意义[J].江苏大学学报(医学版),2012,22(4):350-353.
[33] Babykutty S,S PP,J NR,et al.Nimbolide retards tumor cell migration,invasion,and angiogenesis by downregulating MMP-2/9 expression via Inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells[J].Mol Carcinog,2012,51(6):475-490.
[34] Suboj P,Babykutty S,Valiyaparambil Gopi DR,et al.Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9,RhoB and VEGF via reduced DNA binding activity of NF-κB[J].Euro J Pha Sci,2012,45(5):581-591.
[35] Guo RX,Qiao YH,Zhou Y,et al.Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer[J].Pathol Int,2008,58(12):749-756.
[36] Mahindra A,Laubach J,Raje N,et al.Latest advances and current challenges inthe treatment of multiple myeloma[J].Nat Rev Clin Oncol,2012,9(3):135-143.
[37] Hoesel B,Schmid JA.The complexity of NF-κB signaling in inflammation and cancer[J].Mol Cancer,2013,12(1):1-15.
[38] Li X,Abdel-Mageed AB,Mondal D,et a1.The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers[J].Thyroid,2013,23(2):209-218.
[39] Ding XZ,Tong WG,Adrian TE.Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells[J].Anticancer Res,2000,20(4):2625-2631.

核转录因子-κB通路与肿瘤的研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李哲宏, 吕家兴, 甘新天, 白磊鹏, 曹海营, 金宇. 兔VX2骨肿瘤微环境中IL-4和CD34表达关系[J]. 承德医学院学报, 2021, 38(3): 187-190.
[2]	蒋勇军, 张辉泽, 邝春洁, 刘佳芬, 陈婷. 经尿道行微创钬激光膀胱肿瘤切除术治疗浅表膀胱肿瘤的应用[J]. 承德医学院学报, 2021, 38(2): 103-105.
[3]	李美辰, 潘靖丹, 吴合亮, 张晶晶, 徐雯雯, 杜娈英. 旋毛虫抗原成分抗肿瘤作用的研究进展[J]. 承德医学院学报, 2021, 38(1): 53-56.
[4]	关健华, 张俊琳, 谭银欢, 李伟文, 林启谋. 江门五邑地区乳腺良性肿瘤日间切除的应用研究[J]. 承德医学院学报, 2020, 37(6): 465-468.
[5]	马慧, 郭信伟, 叶宏勋. 胸下段食管癌术后预防照射范围的临床研究[J]. 承德医学院学报, 2020, 37(6): 475-478.
[6]	田庄, 李晓菊, 罗嘉嘉, 黄平, 郭虎, 高源. 肿瘤相关成纤维细胞在乳腺癌发生发展及耐药中的作用[J]. 承德医学院学报, 2020, 37(5): 410-414.
[7]	陈文丽, 庞桂芬, 杨林瀛, 姜锋, 赵志伟, 郑洪飞. 大气道恶性肿瘤103例临床分析[J]. 承德医学院学报, 2020, 37(5): 430-431.
[8]	夏丽娟, 唐旭, 苏平. 热塑体膜固定技术对胸腹部肿瘤放疗患者摆位误差及固定精确度的影响[J]. 承德医学院学报, 2020, 37(4): 330-332.
[9]	屠刚亮, 宋金起, 周亚男, 许长理, 徐辉. 膀胱异位前列腺1例[J]. 承德医学院学报, 2020, 37(3): 254-255.
[10]	刘思洋, 吴建龙, 乔建勇. 侵袭性垂体瘤组织TNF-α与IL-12的表达及意义[J]. 承德医学院学报, 2019, 36(2): 94-97.
[11]	刘祺, 李松涛, 赵桂琴. 肝癌靶向多肽载体的研究进展^*[J]. 承德医学院学报, 2019, 36(2): 159-162.
[12]	岳峰, 欧阳平. 综合护理干预在卵巢恶性肿瘤患者护理中的应用^*[J]. 承德医学院学报, 2019, 36(1): 47-49.
[13]	许长理, 徐辉, 周亚男, 宋金起. 维持性透析患者合并泌尿系肿瘤的临床研究进展[J]. 承德医学院学报, 2019, 36(1): 72-75.
[14]	陈泽城, 邱振华, 周惠娜, 吴红梅. 肿瘤患者感染肺炎克雷伯菌常见产酶的检测及耐药性分析^*[J]. 承德医学院学报, 2018, 35(6): 469-472.
[15]	刘春英, 李冬近, 黎丽婵, 曾会, 彭育男. 延续护理在肿瘤患者PICC置管中的应用[J]. 承德医学院学报, 2018, 35(5): 407-409.